SomnoMed - Snoring & Sleep Apnea Treatment

A CPAP Alternative

  Home | About Us | Latest News | Investor Information | Contact Us | Sales Enquiries


  Product Information


  For Practitioners


 

SomnoMed Investor Information

SomnoMed Annual Reports

SomnoMed Annual Report 2007

SomnoMed Annual Report 2006

SomnoMed Annual Report 2005

SomnoMed Annual Report 2004


SomnoMed ASX Announcements

For a complete list of all ASX Announcements visit
SomnoMed Company Information on ASX

10 June 2008

Investor Update

30 April 2008

Quarterly Report

30 April 2008

SomnoMed accelerates third quarter global unit sales

19 March 2008

SomnoMed Appoints Four Distribution Partners in Europe

18 March 2008

Change of Director’s Interest Notice

17 March 2008

SomnoMed to Benefit from US Medicare decision

25 February 2008

SomnoMed Half Year Financial Report

25 February 2008

SomnoMed Unit Sales up 56% – strongest growth in US

1 January 2008

SomnoMed Receives FDA Approval for New SMH Biomaterial

18 December 2007

SomnoMed signs License Agreement for the USA

12 November 2007

SomnoMed Appoints Head for European Operation

31 October 2007

SomnoMed First Quarter up 34% Due to Jump in US Sales

5 October 2007

Share Placement and Share Purchase Plan

30 August 2007

ASX Preliminary Final Report 30 June 07

1 August 2007

SomnoMed Acquires interest in Swiss Bio Plastic Venture

11 July 2007

New SomnoMed CEO Appointment

5 June 2007

SomnoMed European Expansion